+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Transcatheter Mitral Valve"

North America Interventional Cardiology Devices Market Outlook, 2031 - Product Thumbnail Image

North America Interventional Cardiology Devices Market Outlook, 2031

  • Report
  • March 2026
  • 90 Pages
  • North America
From
From
Asia-Pacific Interventional Cardiology Devices Market Outlook, 2031 - Product Thumbnail Image

Asia-Pacific Interventional Cardiology Devices Market Outlook, 2031

  • Report
  • March 2026
  • 94 Pages
  • Asia Pacific
From
China TAVR & TMV Market: Insights & Forecast (2024-2028) - Product Thumbnail Image

China TAVR & TMV Market: Insights & Forecast (2024-2028)

  • Report
  • June 2024
  • 51 Pages
  • China
From
From
From
From
From
From
Cardiovascular Devices Market Report and Forecast 2025-2034 - Product Thumbnail Image

Cardiovascular Devices Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
From
From
Loading Indicator

The Transcatheter Mitral Valve (TMV) is a type of cardiovascular device used to treat mitral valve regurgitation, a condition in which the mitral valve does not close properly, allowing blood to flow backward into the left atrium. TMV is a minimally invasive procedure that involves the insertion of a prosthetic valve into the heart through a catheter. This procedure is an alternative to open-heart surgery, which is more invasive and carries a higher risk of complications. TMV is a rapidly growing market, with a number of companies developing and marketing products. These companies are focused on improving the safety and efficacy of TMV procedures, as well as expanding the range of patients who can benefit from the procedure. Companies in the TMV market include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, and Neovasc. Show Less Read more